K-RAS GENOTYPING TEST (PHARMACOGENOMICS) 

Description

A K-RAS genotyping test, particularly within the context of pharmacogenomics, is a genetic test that analyzes the KRAS gene for mutations. These mutations can affect a patient’s response to certain cancer therapies, specifically those targeting the EGFR pathway in cancers like colorectal cancer. Understanding the KRAS mutation status allows clinicians to make more informed treatment decisions, potentially improving patient outcomes and avoiding ineffective or harmful therapies.